Tramadol - Nippon Shinyaku/Janssen Pharmaceutica

Drug Profile

Tramadol - Nippon Shinyaku/Janssen Pharmaceutica

Alternative Names: NS-315; Tramal; Tramal OD Tablet

Latest Information Update: 03 Dec 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Grunenthal
  • Developer Nippon Shinyaku
  • Class Antidepressants; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Phenyl ethers; Small molecules
  • Mechanism of Action Opioid mu receptor agonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer pain; Pain

Most Recent Events

  • 08 Mar 2016 Biomarkers information updated
  • 01 Dec 2014 Launched for Cancer pain in Japan (PO, orally disintegrating tablet)
  • 01 Dec 2014 Launched for Pain (chronic) in Japan (PO, orally disintegrating tablet)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top